Thus, the above-mentioned studies and others [102] comprise a large body of evidence that demonstrates that the deregulated p73 contributes to cancer development and progression and that accumulated TAp73 compensates for p53 loss and induces tumor suppression. Here, TP53 is linked to cancer.